| Pharmaceutical Information |
| Drug Name |
Alteplase |
| Drug ID |
BADD_D00087 |
| Description |
Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells |
| Indications and Usage |
For management of acute myocardial infarction, acute ischemic stroke and for lysis of acute pulmonary emboli. |
| Marketing Status |
approved |
| ATC Code |
B01AD02; S01XA13 |
| DrugBank ID |
DB00009
|
| KEGG ID |
D02837
|
| MeSH ID |
D010959
|
| PubChem ID |
22976653
|
| TTD Drug ID |
D07BQE
|
| NDC Product Code |
63552-041; 50242-041; 50242-044; 50242-085 |
| UNII |
1RXS4UE564
|
| Synonyms |
Tissue Plasminogen Activator | Plasminogen Activator, Tissue | Tissue Activator D-44 | Tissue Activator D 44 | Tisokinase | Tissue-Type Plasminogen Activator | Tissue Type Plasminogen Activator | TTPA | T-Plasminogen Activator | T Plasminogen Activator | Alteplase | Plasminogen Activator, Tissue-Type | Plasminogen Activator, Tissue Type | Activase | Actilyse | Lysatec rt-PA | Lysatec rt PA | Lysatec rtPA |
|
| Chemical Information |
| Molecular Formula |
C42H36N2 |
| CAS Registry Number |
177799-16-5 |
| SMILES |
CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=C4C=CC=CC4=C(C5=CC=CC=C53)N(C6=CC=C(C=C6)C)C7=
CC=C(C=C7)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
